Mixed Results for US Stocks 🎢

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Happy Monday! It's January 9th. I hope you have a great weekend! Before we get started, I just want to remind you that you can get free closing bell alerts on your mobile device by texting CLOSE to 47121 or [clicking here](. Sign up now to start the New Year off right and stay up-to-speed on the hottest stocks! Here's what moved the market today: Markets 📈 US benchmarks closed today's session with mixed results. The Nasdaq [+0.6%] rallied, while the Dow [-0.3%] and S&P 500 [<0.0%] took small losses. The small-cap Russell 2K [+0.1%] followed the Nasdaq higher. Sponsored [5 Tech Stocks with 10x Potential]( 🚀 If you had bought Netflix after the dot-com crash, you could have turned $1,000 into over half a million dollars in profit. And today – thanks to the tech crash – you have a similar opportunity. Luke Lango just named 5 tech stocks with 10x potential in a new report (one is trading for just $6). [Get the Complete Watchlist Here.]( Today's Market-Moving News 🔎 🛢 China Reopening Boosts Oil: Crude oil is up 1.3% to about $74.80 a barrel in late session trading, fueled by hopes that China's reopening will boost global demand. Today's Top Winners and Losers 🔥 MultiMetaVerse [MMV] $3.18 (-72.7%) MultiMetaVerse plummeted back to earth after posting an 82% gain on Friday. The company recently made its stock market debut after completing its business combination with Model Performance Acquisition SPAC last week. Moolec Sciences [MLEC] $12.99 (-32.5%) Moolec Sciences also suffered a big pullback after rallying 251% on Friday. The stock began trading on the Nasdaq last Tuesday after the company closed its business combination with Lightjump Acquisition SPAC. Cerus Corp [CERS ://elitetra.de/L2Ic ] $2.72 (-28.0%) Cerus Corp reported disappointing preliminary Q4 results today. Product revenue of $44 million missed analysts' $44.5 million estimate. The company also issued 2023 guidance of $165 million to $175 million, falling well short of the consensus estimate of $193.3 million. CinCor Pharma [CINC] $28.74 (+143.9%) CinCor Pharma agreed to a buyout deal with British pharma giant AstraZeneca [AZN +0.1%] for $26 per share, plus a contingent value right (CVR) for another $10 per share triggered on a regulatory submission for baxdosat. The deal is worth up to $1.8 billion with the included CVRs. Amryt Pharma [AMYT] - $14.51 (+107.2%) Amryt Pharma agreed to be acquired by Italy-based Chiese Farmaceutici for $14.50 per American depository share, plus a $2.50 CVR. The upfront cost of the deal is $1.25 billion, and the CVR will add another $225 million to the price if it is triggered. Albireo Pharma [ALBO] $43.85 (+92.1%) Albireo Pharma agreed to a $952 million buyout deal with Ipsen [IPSEY -1.8%] that will pay $42 per share, plus a $10 CVR. The CVR payment will trigger if the newly-combined company can obtain FDA approval of Bylvay by Dec. 31, 2027. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](